Market revenue in 2023 | USD 940.3 million |
Market revenue in 2030 | USD 2,613.3 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.88% in 2023. Horizon Databook has segmented the Colombia non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
Bogota is the main hub for aesthetic services in Colombia. Key market drivers include increasing aesthetic consciousness among people, availability of new markets, growing international investments in aesthetic market, increasing baby boomer population, and high awareness & adoption of aesthetic procedures among individuals.
In Colombia, approximately 157,896 minimally invasive procedures were performed in 2020, out of which 111,924 were injectable procedures, 15,336 were facial rejuvenation procedures, and 30,636 were hair removal & fat reduction procedures, according to International Society of Aesthetic Plastic Surgery. Medical tourism for plastic surgery is growing at a rapid rate in Colombia.
Various factors such as economic slowdown, extremely competitive environment, low purchasing power, and insufficiently regulated market are responsible for the slow growth in the country. For cosmetic products, Colombia follows CAN Decision 516 with its amendments: Decision 777 and Resolutions 797 & 1333.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into Colombia non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account